Cargando…

Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin

PURPOSE: Eribulin is a unique anti-cancer drug which can improve overall survival (OS) of patients with metastatic breast cancer (MBC), probably by modulating the tumor immune microenvironment. The aim of this study was to investigate the clinical significance of serum levels of immune-related and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bun, Ayako, Nagahashi, Masayuki, Kuroiwa, Mamiko, Komatsu, Miki, Miyoshi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564839/
https://www.ncbi.nlm.nih.gov/pubmed/37733188
http://dx.doi.org/10.1007/s10549-023-07086-9

Ejemplares similares